Real-time enrollment status for this amyotrophic lateral sclerosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:08 AM UTC
| NCT Number | NCT07290062 |
| Recruiting Status | Recruiting |
| Condition | Amyotrophic Lateral Sclerosis |
| Phase | PHASE1 |
| Target Enrollment | 23 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Insmed Gene Therapy LLC |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT07290062 is currently recruiting participants. This phase1 study for amyotrophic lateral sclerosis is actively seeking new participants at 5 locations across the United States. The study is sponsored by Insmed Gene Therapy LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07290062 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07290062 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.